JULIANA KIM: Open Payments
NPI 1215712146 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 29 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $817 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $247 |
| ABBVIE INC. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Auvelity, VRAYLAR, HETLIOZ, Jornay PM, REXULTI, ABILIFY ASIMTUFII, CAPLYTA, FANAPT.
Industry payments across VA — which companies pay providers there.
